title: Uracil DNA Glycosylase 2 negatively regulates HIV-1 LTR transcription.
abstract: Numerous cellular factors belonging to the DNA repair machineries, including RAD18, RAD52, XPB and XPD, have been described to counteract human immunodeficiency virus type 1 (HIV-1) replication. Recently, Uracil DNA glycosylase 2 (UNG2), a major determinant of the uracil base excision repair pathway, was shown to undergo rapid proteasome-dependent degradation following HIV-1 infection. However, the specific role of intracellular UNG2 depletion during the course of HIV-1 infection is not clearly understood. Our study shows for the first time that overexpression of UNG2 inhibits HIV-1 replication. We demonstrate that this viral inhibition is correlated with a marked decrease in transcription efficiency as shown by monitoring HIV-1 LTR promoter activity and quantification of HIV-1 RNA levels. Interestingly, UNG2 inhibits LTR activity when stimulated by Tat transactivator or TNFalpha, while barely affected using Phorbol ester activation. Mutational analysis of UNG2 indicates that antiviral activity may require the integrity of the UNG2 catalytic domain. Altogether, our data indicate that UNG2 is likely to represent a new host defense factor specifically counteracted by HIV-1 Vpr. The molecular mechanisms involved in the UNG2 antiviral activity still remain elusive but may rely on the sequestration of specific cellular factor(s) critical for viral transcription.
authors.affiliation: Université Montpellier 1, Centre d'études d'agents Pathogènes et Biotechnologies pour la Santé, CNRS, UMR 5236, CPBS, F-34965 Montpellier, France.
authors.forename: David
authors.initials: D
authors.lastname: Fenard
authors.forename: Laurent
authors.initials: L
authors.lastname: Houzet
authors.forename: Eric
authors.initials: E
authors.lastname: Bernard
authors.forename: Audrey
authors.initials: A
authors.lastname: Tupin
authors.forename: Sonia
authors.initials: S
authors.lastname: Brun
authors.forename: Marylène
authors.initials: M
authors.lastname: Mougel
authors.forename: Christian
authors.initials: C
authors.lastname: Devaux
authors.forename: Nathalie
authors.initials: N
authors.lastname: Chazal
authors.forename: Laurence
authors.initials: L
authors.lastname: Briant
mesh_terms: D020134:Catalytic Domain; D002460:Cell Line; D019427:HIV Integrase / Q000378:metabolism; D016325:HIV Long Terminal Repeat; D015497:HIV-1 / Q000235:genetics* / Q000502:physiology; D015498:HIV-2 / Q000502:physiology; D006801:Humans; D011401:Promoter Regions, Genetic; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects; D015533:Transcriptional Activation; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D051981:Uracil-DNA Glycosidase / Q000737:chemistry / Q000378:metabolism*; D014771:Virion / Q000502:physiology; D054322:tat Gene Products, Human Immunodeficiency Virus / Q000378:metabolism; D054325:vpr Gene Products, Human Immunodeficiency Virus / Q000378:metabolism
chemical_list: D014409:Tumor Necrosis Factor-alpha; D054322:tat Gene Products, Human Immunodeficiency Virus; D054325:vpr Gene Products, Human Immunodeficiency Virus; C514912:vpr protein, Human immunodeficiency virus 1; D019427:HIV Integrase; D051981:Uracil-DNA Glycosidase; D046988:Proteasome Endopeptidase Complex; D013755:Tetradecanoylphorbol Acetate; C514801:p31 integrase protein, Human immunodeficiency virus 1
references.citation: J Virol. 2006 Jan;80(2):875-82
references.pmid: 16378989
references.citation: Retrovirology. 2008 Jul 07;5:57
references.pmid: 18605989
references.citation: Biochemistry. 1995 Jan 10;34(1):128-38
references.pmid: 7819187
references.citation: Nucleic Acids Res. 1997 Feb 15;25(4):750-5
references.pmid: 9016624
references.citation: J Virol. 1996 Feb;70(2):697-704
references.pmid: 8551605
references.citation: J Virol. 2005 Sep;79(17):10978-87
references.pmid: 16103149
references.citation: Virology. 2003 Mar 15;307(2):283-9
references.pmid: 12667798
references.citation: Retrovirology. 2007 May 02;4:30
references.pmid: 17474982
references.citation: Cell. 1995 Mar 24;80(6):869-78
references.pmid: 7697717
references.citation: PLoS Pathog. 2006 May;2(5):e40
references.pmid: 16710452
references.citation: Science. 2003 Nov 7;302(5647):1056-60
references.pmid: 14564014
references.citation: Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4130-5
references.pmid: 17360488
references.citation: J Biol Chem. 2008 Dec 19;283(51):35383-92
references.pmid: 18945672
references.citation: J Virol. 1999 Feb;73(2):1682-8
references.pmid: 9882380
references.citation: J Biol Chem. 2002 Oct 18;277(42):39926-36
references.pmid: 12161446
references.citation: J Biol Chem. 2003 Sep 12;278(37):35211-9
references.pmid: 12842892
references.citation: Nature. 2002 Aug 8;418(6898):646-50
references.pmid: 12167863
references.citation: EMBO J. 2004 Aug 18;23(16):3421-9
references.pmid: 15297876
references.citation: J Virol. 2006 Nov;80(22):11178-90
references.pmid: 16928741
references.citation: J Virol. 1997 Jun;71(6):4842-6
references.pmid: 9151883
references.citation: J Biol Chem. 2001 Sep 7;276(36):33569-75
references.pmid: 11438542
references.citation: Retrovirology. 2005 Feb 22;2:11
references.pmid: 15725353
references.citation: Biophys J. 2004 Apr;86(4):1922-45
references.pmid: 15041638
references.citation: Nat Rev Immunol. 2004 Nov;4(11):868-77
references.pmid: 15516966
references.citation: Nat Med. 2002 Jul;8(7):681-6
references.pmid: 12042777
references.citation: J Mol Biol. 2006 Dec 15;364(5):1034-47
references.pmid: 17054986
references.citation: Mol Cell. 2005 Feb 18;17(4):479-90
references.pmid: 15721252
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4622-7
references.pmid: 16537383
references.citation: J Virol. 2000 Aug;74(15):7039-47
references.pmid: 10888643
references.citation: Nat Rev Mol Cell Biol. 2008 Apr;9(4):297-308
references.pmid: 18285803
references.citation: J Biol Chem. 2004 Jul 2;279(27):28419-25
references.pmid: 15096517
references.citation: AIDS Rev. 2005 Jan-Mar;7(1):26-43
references.pmid: 15875659
references.citation: Mol Cell. 2000 Jun;5(6):1059-65
references.pmid: 10912000
references.citation: DNA Repair (Amst). 2007 Apr 1;6(4):489-504
references.pmid: 17116428
references.citation: DNA Repair (Amst). 2007 Apr 1;6(4):517-29
references.pmid: 17129768
references.citation: Mol Cell Biol. 2005 Jun;25(11):4388-96
references.pmid: 15899845
references.citation: EMBO J. 2008 Jan 9;27(1):51-61
references.pmid: 18079698
references.citation: J Biol Chem. 2003 Feb 14;278(7):4566-71
references.pmid: 12458223
references.citation: Nucleic Acids Res. 2007;35(8):2695-704
references.pmid: 17426127
references.citation: J Biol Chem. 2003 Jun 6;278(23):20724-30
references.pmid: 12670953